Injexate

Methotrexate, the active ingredient in Injexate, is a folate antagonist antimetabolite presented as a subcutaneous injection for systemic use. It is employed as an immunosuppressant and disease‑modifying antirheumatic drug to treat autoimmune disorders and certain malignancies.

GNH USA supplies Injexate as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. Our distribution network ensures consistent quality and regulatory compliance across EU and global markets, providing reliable access for healthcare providers. We partner with accredited logistics firms to maintain product integrity during transport.

Methotrexate is used in several autoimmune and oncologic disease pathways. - Rheumatoid arthritis: reduces joint inflammation and slows structural damage. - Psoriasis: improves skin lesions and decreases disease severity. - Acute lymphoblastic leukemia: contributes to remission by inhibiting malignant cell proliferation. - Non‑Hodgkin lymphoma: used as part of combination regimens to achieve tumor control.

Methotrexate may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Nausea or vomiting: gastrointestinal upset occurring early in therapy. - Fatigue: general tiredness or reduced energy. - Mouth sores: ulceration of oral mucosa. - Elevated liver enzymes: mild hepatic irritation. - Low blood cell counts: mild leukopenia or anemia.

Serious or Rare Side Effects: - Severe liver toxicity: potential for hepatitis or fibrosis. - Pulmonary fibrosis: interstitial lung disease with breathing difficulty. - Bone marrow suppression: profound pancytopenia. - Renal impairment: acute kidney injury from drug accumulation.

Before initiating methotrexate therapy, several safety considerations should be reviewed. - Pregnancy: contraindicated (Category X); avoid use in pregnant or planning patients. - Renal function: assess creatinine clearance and adjust if impaired. - Liver function: perform baseline transaminases and monitor regularly. - Hematologic status: obtain complete blood count prior to start and during treatment. - Concomitant vaccines: avoid live vaccines while on therapy. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze.

Methotrexate interacts with several medicines that can alter its efficacy or increase toxicity.

Major Interactions (Avoid): - Non‑steroidal anti‑inflammatory drugs (NSAIDs): may increase methotrexate serum levels and risk renal toxicity. - Proton pump inhibitors (e.g., omeprazole): can reduce renal clearance and raise drug exposure. - Trimethoprim‑sulfamethoxazole: potentiates bone marrow suppression.

Moderate Interactions (Monitor Closely): - Azathioprine or mycophenolate: additive immunosuppression may increase infection risk. - Live vaccines: may cause severe infection due to immunosuppression. - Alcohol: can exacerbate hepatic toxicity.